MR-Spectroscopy offers a unique potential to characterize underlying neuronal mechanisms of psychiatric dysfunctions and the effects of psychoactive drugs, at a fundamental neuro-metabolite level in-vivo. We studied two preclinical disease models: the chronic mild unpredictable stress (CMUS) model, a putative model for depression, and a sub-chronic memantine (NMDA antagonist) model, a putative model for psychosis using single voxel spectroscopy (SVS). Our results represents metabolic fingerprinting of dysfunctions utilising live metabolic flux profiling; documenting neuro-metabolic effects of novel psycho-active drugs, presenting novel insights in-vivo. Our results and unique approach, exemplifies the potential value of SVS in early stage drug discovery and its potential translation to clinical research.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords